MCLAUGHLIN JOHN PETER

CIK 00012779676 companiesBOTHELL, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001277967

Recent Transactions

50 trades

Award
LENSAR, Inc.$LNSR
Stock Option (Right to Buy)
2023-05-25+33,175→ 33,175 total
Award
LENSAR, Inc.$LNSR
Common Stock
2023-05-25+9,288→ 53,631 total
Award
LENSAR, Inc.$LNSR
Stock Option (Right to Buy)
2022-05-25+15,616→ 15,616 total
Award
LENSAR, Inc.$LNSR
Common Stock
2022-05-25+4,285→ 44,343 total
Award
ROCKWELL MEDICAL, INC.$RMTI
Stock Option (Right to Buy)
2021-06-17+72,857→ 72,857 total
Award
ROCKWELL MEDICAL, INC.$RMTI
Common Stock
2021-06-17+50,000→ 136,974 total
Award
LENSAR, Inc.$LNSR
Stock Option (Right to Buy)
2021-05-18+20,847→ 20,847 total
Award
LENSAR, Inc.$LNSR
Stock Option (Right to Buy)
2021-03-12+13,445→ 13,445 total
Award
LENSAR, Inc.$LNSR
Stock Option (Right to Buy)
2021-02-01+28,249→ 28,249 total
Sale
PDL BIOPHARMA, INC.
Common stock
2020-12-22$2.61/sh−277,934→ 200,000 total
Sale
PDL BIOPHARMA, INC.
Common stock
2020-12-21$2.62/sh−50,000→ 477,934 total
Award
PDL BIOPHARMA, INC.
Common stock
2020-08-19+25,826→ 527,934 total
Award
PDL BIOPHARMA, INC.
Stock Option (right to buy)
2020-08-19$3.63/sh+118,671→ 118,671 total
Award
ROCKWELL MEDICAL, INC.$RMTI
Common Stock
2020-05-18+51,800→ 86,974 total
Award
ROCKWELL MEDICAL, INC.$RMTI
Stock Option (Right to Buy)
2020-05-18+34,024→ 34,024 total
Award
ROCKWELL MEDICAL, INC.$RMTI
Common Stock
2020-01-29+12,615→ 35,174 total
Award
ROCKWELL MEDICAL, INC.$RMTI
Stock Option (Right to Buy)
2019-09-05+28,372→ 28,372 total
Award
ROCKWELL MEDICAL, INC.$RMTI
Common Stock
2019-09-05+22,559→ 22,559 total
Award
PDL BIOPHARMA, INC.
Stock Option (right to buy)
2019-06-20$3.00/sh+126,050→ 126,050 total
Disposition to Issuer
PDL BIOPHARMA, INC.
Common stock
2018-12-31−123,449→ 502,108 total
Disposition to Issuer
PDL BIOPHARMA, INC.
Common stock
2018-12-27−627,228→ 625,557 total
Award
PDL BIOPHARMA, INC.
Stock Option (right to buy)
2018-06-08+1,922,100→ 1,922,100 total
Disposition to Issuer
PDL BIOPHARMA, INC.
Common stock
2017-12-15−151,678→ 1,252,785 total
Award
PDL BIOPHARMA, INC.
Common stock
2017-03-04$2.04/sh+588,235→ 1,404,463 total
Disposition to Issuer
PDL BIOPHARMA, INC.
Common stock
2016-12-13−5,168→ 816,228 total
Award
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2016-05-20+9,260→ 9,260 total
Award
Seagen Inc.
Common Stock
2016-05-20+3,700→ 39,400 total
Award
Adverum Biotechnologies, Inc.
Common Stock
2016-02-12+8,333→ 10,333 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2016-02-12+11,905→ 11,905 total
Award
PDL BIOPHARMA, INC.
Common stock
2016-01-26$3.22/sh+403,727→ 821,396 total
Award
Seagen Inc.
Common Stock
2015-05-15+3,700→ 35,700 total
Award
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2015-05-15+9,260→ 9,260 total
Award
Adverum Biotechnologies, Inc.
Common Stock
2015-04-21+2,000→ 2,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2015-04-21+7,000→ 7,000 total
Award
PDL BIOPHARMA, INC.
Common stock
2015-01-28$7.62/sh+129,201→ 417,669 total
Conversion
Adverum Biotechnologies, Inc.
Common Stock
2014-08-05+13,280→ 13,280 total
Conversion
Adverum Biotechnologies, Inc.
Series B Preferred Stock
2014-08-05−13,280→ 0 total
Conversion
Adverum Biotechnologies, Inc.
Common Stock
2014-08-05+13,280→ 13,280 total
Conversion
Adverum Biotechnologies, Inc.
Series B Preferred Stock
2014-08-05−13,280→ 0 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2014-07-30+75,000→ 75,000 total
Award
Seagen Inc.
Common Stock
2013-05-17+3,500→ 28,500 total
Award
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2013-05-17$36.70/sh+8,750→ 8,750 total
Award
PDL BIOPHARMA, INC.
Common Stock
2013-01-24$6.72/sh+29,911→ 168,698 total
Award
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2012-05-18$20.06/sh+17,500→ 17,500 total
Award
PDL BIOPHARMA, INC.
Common stock
2012-01-18$6.29/sh+31,955→ 138,787 total
Exercise/Conversion
Seagen Inc.
Common Stock
2011-09-09$9.82/sh+25,000→ 25,000 total
Exercise/Conversion
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2011-09-09−25,000→ 0 total
Award
PDL BIOPHARMA, INC.
Common Stock
2011-05-23+30,501→ 106,832 total
Award
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2011-05-20$19.02/sh+17,500→ 17,500 total
Award
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2010-05-21$12.76/sh+17,500→ 17,500 total

MCLAUGHLIN JOHN PETER

Recent Transactions

Companies

Recent Filings

Address